Dania Caron

Author PubWeight™ 7.12^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.	Cancer Immun	2004	1.15
2	Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.	J Immunother	2006	0.93
3	Multiple signals are required for maturation of human dendritic cells mobilized in vivo with Flt3 ligand.	J Leukoc Biol	2002	0.89
4	Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant.	J Clin Immunol	2003	0.88
5	Mobilization of dendritic cell precursors in patients with cancer by flt3 ligand allows the generation of higher yields of cultured dendritic cells.	J Immunother	2002	0.87
6	Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers.	Blood	2002	0.86
7	Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer.	Clin Cancer Res	2004	0.84
8	The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults.	Vaccine	2002	0.77